Lack of effect of benralizumab on signs and symptoms of moderate-to-severe atopic dermatitis: Results from the phase 2 randomized, double-blind, placebo-controlled HILLIER trial.
作者信息
Guttman-Yassky E, Bahadori L, Brooks L, Clark K L, Grindebacke H, Ho C N, Katial R, Pham T-H, Walton C, Datto C J
机构信息
Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Late Stage Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, USA.
出版信息
J Eur Acad Dermatol Venereol. 2023 Oct;37(10):e1211-e1214. doi: 10.1111/jdv.19195. Epub 2023 Jun 12.
PMID:37178404
Abstract
摘要
Zotero 插件